Redesign Science Inc is a computational chemistry company that is interested in small molecule drug discovery
Redesign Science Inc is a computational chemistry company that is interested in small molecule drug discovery. The company was founded by David Rooklin and Haotian Li in 2017 in New York, New York, United States.